Abstract:
:The pathogenesis and therapy of shrinking lungs syndrome in patients with systemic lupus erythematosus remains controversial. It has been previously reported that corticosteroid treatment can be effective. We report a patient with shrinking lungs syndrome who presented a good response to inhaled beta-agonist therapy. Therapeutic approach to this syndrome is discussed.
journal_name
Lupusjournal_title
Lupusauthors
Muñoz-Rodríguez FJ,Font J,Badia JR,Miret C,Barberà JA,Cervera R,Ingelmo Mdoi
10.1177/096120339700600413subject
Has Abstractpub_date
1997-01-01 00:00:00pages
412-4issue
4eissn
0961-2033issn
1477-0962journal_volume
6pub_type
杂志文章相关文献
LUPUS文献大全abstract::Background Musculoskeletal involvement is extremely common in patients with systemic lupus erythematosus (SLE). Continuing the research initiated in patients with inflammatory arthritis, recent studies have shown the potential role of musculoskeletal ultrasound (MSUS) in the evaluation of clinical and subclinical lupu...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203316662723
更新日期:2017-03-01 00:00:00
abstract::Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of systemic lupus erythematosus (SLE). Cases complicated with DAH often have active SLE with multi-organ involvement, especially lupus nephritis. We describe a rare case of DAH as the first presenting manifestation of SLE in the absence of lupus neph...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203311411353
更新日期:2011-12-01 00:00:00
abstract:OBJECTIVE:Systemic lupus erythematosus (SLE) is a chronic, relapsing-remitting autoimmune disorder that involves multiple organ systems including the central nervous system. Among the items included in the nomenclature for neuropsychiatric SLE, mood disorders have been identified. The aim of this paper is to review the...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/0961203313477227
更新日期:2013-04-01 00:00:00
abstract::We report a case of drug-induced lupus erythematosus (DILE) secondary to trimethoprim/sulfamethoxazole (TMP/SMX) in a patient with underlying inflammatory bowel disease (IBD). The initial presentation was with febrile pleural and pericardial effusions followed by cardiac tamponade. The patient was treated with a short...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203316657435
更新日期:2017-03-01 00:00:00
abstract::Monoclonal antiphospholipid antibodies (aPL) have been utilized to dissect the relationship between their sequence, structure, binding and biological properties relevant to the pathogenesis of the antiphospholipid syndrome. In particular, sequence analysis of aPL has highlighted the clustering of certain amino acid re...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203309360809
更新日期:2010-04-01 00:00:00
abstract::Intestinal pseudo-obstruction (IpsO) occurs in a small subgroup of patients with systemic lupus erythematosus (SLE), and has been under-recognized. The etiology and mechanisms are unclear. Herein, we report two cases. In case 1, IpsO occurred as the complication in a previously diagnosed SLE patient. In case 2, IpsO w...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/0961203311405702
更新日期:2011-10-01 00:00:00
abstract::Associations of polymorphisms in vitamin D receptor (VDR) with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have already been explored by many studies. The aim of this meta-analysis was to better clarify associations between polymorphisms in VDR and RA/SLE by combing the results of all relevant stu...
journal_title:Lupus
pub_type: 杂志文章,meta分析
doi:10.1177/0961203320909432
更新日期:2020-04-01 00:00:00
abstract::In examining reasons for premature atherosclerosis in systemic lupus erythematosus (SLE), we previously reported low levels of the cholesterol transport protein apolipoprotein A1 (apoA1) in these patients, and specific antibodies to purified apoA1 were identified in the sera of 5 out of 30 lupus patients. The current ...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/096120398678920262
更新日期:1998-01-01 00:00:00
abstract::In a 76-week, randomized controlled trial, patients received 100 mg LJP 394 or placebo weekly for 16 weeks followed by three 12-week treatment cycles of 50 mg LJP 394 or placebo weekly each separated by eight-week periods when no therapy was administered. Health-related quality of life (HRQOL) was assessed using SF-36...
journal_title:Lupus
pub_type: 临床试验,杂志文章,多中心研究,随机对照试验
doi:10.1191/0961203303lu440oa
更新日期:2003-01-01 00:00:00
abstract:OBJECTIVE:Systemic lupus erythematosus (SLE), an autoimmune condition with diverse clinical manifestations, is reported to have different expression in populations of different ancestry. Most previous studies compared patients of different ethnic groups from geographically distinct cohorts. In our study, we aimed to ch...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203313500547
更新日期:2013-11-01 00:00:00
abstract::We report clinical and histopathological features, treatment and outcome of 37 Croatian children with biopsy-proven lupus nephritis seen over a 30-year period. The mean age at lupus nephritis presentation was 12.11 ± 2.59 years (range 4.66-17.0). The most frequent histopathological finding was class IV (37.8%), follow...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203314563133
更新日期:2015-03-01 00:00:00
abstract::Objectives The objective of this study was to determine whether advanced MRI could provide biomarkers for diagnosis and prognosis in neuropsychiatric systemic lupus erythematosus (NPSLE). Methods Our prospective study included 28 systemic lupus erythematosus (SLE) patients with primary central NPSLE, 22 patients witho...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203316674820
更新日期:2017-04-01 00:00:00
abstract::Recent accumulated evidence suggests that prolactin (PRL) is an important immunomodulator and might have a role in the pathogenesis of systemic lupus erythematosus (SLE). Our aim was to assess the frequency of hyperprolactinemia in women with SLE and to evaluate its correlation with disease activity. PRL plasma levels...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/096120398678920361
更新日期:1998-01-01 00:00:00
abstract:OBJECTIVE:To examine the potential immunologic mechanism and involvement of antiphospholipid antibodies in the pathogenesis of heart valve lesions in patients with the antiphospholipid syndrome (APS). METHODS:Immunoperoxidase and immunofluorescence staining methods were used to evaluate 13 heart valve specimens derive...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339600500306
更新日期:1996-06-01 00:00:00
abstract::Although many types of neurological disorders and events have been described in association with antiphospholipid antibodies (aPL) and the antiphospholipid syndrome (APS), only ischaemic stroke is reasonably well established and accepted as a diagnostic criterion for the syndrome. We propose to evaluate, classify and ...
journal_title:Lupus
pub_type: 共识发展会议,杂志文章,评审
doi:10.1191/0961203303lu392oa
更新日期:2003-01-01 00:00:00
abstract::Objective The objectives of this paper are to objectively measure habitual physical activity levels in patients with primary Sjögren's syndrome (pSS) with mild disease activity and to determine to which extent it may be associated with physical capacity and function and clinical features. Methods In this cross-section...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203316674819
更新日期:2017-06-01 00:00:00
abstract:OBJECTIVE:To investigate the relationship between antimalarials (AM) and elevated muscle enzymes in systemic lupus erythematosus (SLE). PATIENTSMETHODS:325 lupus patients with abnormal creatine phosphokinase (CPK) for at least two consecutive clinic visits were enrolled; 54 patients on statins/fibrates (n = 43) and/or...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203315617845
更新日期:2016-04-01 00:00:00
abstract::Diagnostic strategy studies commonly focus on the accuracy of tests in diagnosing, and grading this body of evidence is a challenge in itself because (1) standard tools for grading evidence were designed for questions about treatment rather than diagnostic testing; and (2) the clinical usefulness of a diagnostic strat...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203314543922
更新日期:2014-10-01 00:00:00
abstract:OBJECTIVE:We aimed to develop a model of the illness experience for youth with systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD). METHODS:We conducted 32 semi-structured interviews with 16 outpatient youth with SLE/MCTD, age 11 to 22 years, and their parents. We qualitatively defined key featur...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203316646460
更新日期:2016-08-01 00:00:00
abstract::Neuropsychiatric lupus is a well-recognized complication of systemic lupus erythematosus (SLE) and encompasses a wide variety of neurological manifestations. Although isolated cranial nerve involvement is rare, it can cause significant morbidity and disability. This report describes a case with isolated vagus nerve in...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203307080632
更新日期:2007-01-01 00:00:00
abstract::Anti-idiotypic antibody and its F(ab')2 fragments prepared from pooled normal human IgG had a partial inhibitory effect on the spontaneous in vitro secretion of anti-DNA antibodies from blood mononuclear cells of lupus patients. The inhibitory effect was specific for anti-DNA secretion as the anti-idiotype failed to i...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339300200607
更新日期:1993-12-01 00:00:00
abstract::Antiphospholipid antibodies (aPL), the majority of which are directed against beta(2)-glycoprotein I (beta(2)GPI), are associated with an increased incidence of venous and arterial thrombosis. The pathogenesis of antiphospholipid/anti-beta(2)GPI-associated thrombosis has not been defined, and is likely multifactorial....
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/0961203308095329
更新日期:2008-10-01 00:00:00
abstract:OBJECTIVE:Subepidermal bullous lesions and toxic epidermal necrolysis-like (TEN-like) lesions can occur in patients with systemic lupus erythematosus (SLE). In this report, we describe a case of a patient previously diagnosed with SLE who experienced TEN-like skin lesions with unusual subacute progression in the contex...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/0961203313492242
更新日期:2013-07-01 00:00:00
abstract::Endothelial and/or platelet activation likely initiates thrombus formation. Whether antiphospholipid antibody (aPL) is an activator, a toxic response, or a protective response is not clear, nor is it certain whether aPL is germ-line encoded or antigen-driven. The pregnancy model is particularly informative. Alternativ...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1177/096120339600500514
更新日期:1996-10-01 00:00:00
abstract::Tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) play a main role in inducing acute phase protein production by hepatocytes. This study describes the serum levels of TNF alpha and IL-6 in relation to serum levels of C-reactive protein (CRP) and alpha 1-acid glycoprotein (alpha 1AG) in three systemic lu...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/096120339300200605
更新日期:1993-12-01 00:00:00
abstract::This study assessed the expression of complement receptor 1 (CR1), decay accelerating factor (DAF) and membrane inhibitor of reactive lysis (CD59) on the erythrocytes and glomerulus of diffuse proliferative glomerulonephritis (DPGN) of systemic lupus erythematosus (SLE) patients using flow cytometry and immunofluoresc...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/096120300678828154
更新日期:2000-01-01 00:00:00
abstract::Twelve systemic lupus erythematosus (SLE) patients with mild to moderate disease activity (SLEDAI of > or = 6 and on prednisolone < 0.5 mg/kg/day) were included in a prospective, randomized, double-blind, placebo-controlled pilot study for 24 weeks. Six were randomized to receive oral leflunomide and six received plac...
journal_title:Lupus
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1191/0961203304lu1067sr
更新日期:2004-01-01 00:00:00
abstract::The antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity in the presence of antiphospholipid antibodies (aPL). Among the thrombogenic mechanisms proposed, it has been suggested that aPL can stimulate tissue factor (TF) expression by endothelial cells (ECs) and monocytes. Moreover, ...
journal_title:Lupus
pub_type: 杂志文章,评审
doi:10.1191/0961203306lu2276rr
更新日期:2006-01-01 00:00:00
abstract::Objectives The carotid intima-media thickness (CIMT) and carotid arterial stiffness index (CASI) act as the surrogate markers of atherosclerosis. We aim to assess CIMT and CASI in pediatric systemic lupus erythematosus (SLE). Methods Patients ≤ 20 years old fulfilling diagnostic criteria for SLE were enrolled. Patient...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1177/0961203317692434
更新日期:2017-08-01 00:00:00
abstract::The objective of the study was to analyse the prevalence and clinical significance of hypocomplementemia in a large series of patients diagnosed either with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (APS) and its association with the main clinical, hematological and immunological fea...
journal_title:Lupus
pub_type: 杂志文章
doi:10.1191/0961203304lu1080oa
更新日期:2004-01-01 00:00:00